Healthier Choices Management Corp. (HCMC) 2025 Annual Report: Critical Investor Takeaways

1. Key Points from the 2025 Annual Report

• Stock Listing & Market Activity:
  HCMC’s common stock is traded on the OTC Pink Marketplace under the symbol “HCMC”. As of March 27, 2026, the closing price was \$0.0001 per share, with approximately 1,400 shareholders of record. The company also has outstanding shares of Series E Redeemable Convertible Preferred Stock.
• Debt Restructuring & Liquidity Improvements:
  In December 2025, HCMC settled \$4 million in related-party debt through equity issuance, eliminating a significant liability and strengthening the balance sheet. Additionally, the company secured an undrawn \$5 million credit line, available through December 31, 2026, providing immediate liquidity for working capital needs.
• Ongoing Losses and Negative Working Capital:
  As of December 31, 2025, HCMC reported a cash balance of \$1.1 million and negative working capital of \$0.3 million. The company continues to incur recurring net losses and does not generate positive cash flow from operations. Management expects losses to continue for the foreseeable future.
• Recent Major Transaction:
  On February 1, 2026, HCMC restructured approximately \$1.3 million in outstanding accounts payable with a vendor. This included issuing a non-interest-bearing promissory note for \$875,000 and 2 billion shares of common stock, valued at \$0.0001 per share (\$200,000), with a portion recharacterized as a contingent fee arrangement tied to ongoing patent litigation.
• Internal Controls & Material Weaknesses:
  Management concluded that internal controls over financial reporting were ineffective as of December 31, 2025, due to material weaknesses in IT access, program change management, and third-party service provider oversight. An action plan is being implemented, including new hires with internal control expertise and business intelligence initiatives, but these weaknesses remain unresolved as of the report date.
• Pending and Past Legal Issues:
  The company reports no ongoing legal proceedings requiring disclosure under Item 103 of Regulation S-K. However, the restructuring of past liabilities includes a component related to ongoing patent litigation.
• Going Concern Warning:
  The financial statements are prepared under the assumption that HCMC will continue as a going concern. However, the company’s negative working capital, continued losses, and dependence on successful execution of management’s plans raise substantial doubt about its ability to continue as a going concern.
• Plans to Address Financial Challenges:
  • Continued cost management and reduction initiatives, especially consulting and operational optimization post spin-off of HCWC.
  • Active pursuit of licensing, commercialization, and strategic partnerships for product lines.
  • Evaluation of additional financing alternatives, including equity offerings or strategic investments.
• No Material Impact from Climate Change:
  HCMC states that climate change is not currently a material risk to operations or financial performance, but the company will continue to monitor for indirect impacts.
• Non-Accelerated Filer & Smaller Reporting Company:
  HCMC is a non-accelerated filer, a smaller reporting company, and not an emerging growth company. The company is subject to reduced disclosure requirements.

2. Potentially Price-Sensitive Information for Shareholders

• Debt Restructuring & Vendor Settlement:
  The settlement of \$4 million in related-party debt and the February 2026 vendor agreement, which involved the issuance of 2 billion shares, significantly affects the company’s capital structure and could impact share value due to potential dilution.
• Ongoing Losses and Negative Working Capital:
  The company’s continued inability to generate positive cash flow or profits, combined with negative working capital, raises substantial doubt about its financial viability and may weigh on share price.
• Material Weaknesses in Internal Controls:
  The persistent material weaknesses in internal controls over financial reporting and the company’s failure to remedy these issues could undermine investor confidence and impact valuation.
• Liquidity Position & Credit Line:
  The \$5 million available credit line provides a short-term liquidity backstop, but the company’s ability to manage expenses and raise additional capital is critical and uncertain.
• Share Issuance and Potential Dilution:
  The issuance of billions of new shares as part of the February 2026 agreement is highly dilutive to existing shareholders and could lead to downward pressure on the share price.

3. Additional Details of Note

• HCMC is not a shell company, is not required to file transition reports, and is current with its SEC reporting obligations.
• The company’s Board of Directors is responsible for long-term oversight, with standing committees and written charters, but is not involved in day-to-day operations.
• The company’s financial statements are prepared in accordance with GAAP and do not contain restatements or error corrections requiring compensation clawbacks.
• There have been no changes in or disagreements with the company’s accountants.
• No unresolved SEC staff comments and no mine safety disclosures are required.
• No dividends are currently declared or paid. The company’s ability to pay dividends in the future is constrained by its financial position and ongoing losses.

4. Financial Highlights (2025 vs. 2024)

• Cash: \$1.14 million at December 31, 2025 (down from \$1.19 million in 2024).
• Total Assets: \$1.47 million at December 31, 2025 (down from \$2.22 million in 2024).
• Net Cash Used in Operating Activities: \$(3.88) million (2025) vs. \$(579,557) (2024).
• Net Cash from Financing Activities: \$3.37 million (2025) vs. \$(1.84) million (2024).
• Adjusted EBITDA: \$(3.59) million (2025) vs. \$(3.81) million (2024).

5. Management’s Forward-Looking Statements

The company cautions that all forward-looking statements are subject to risks and uncertainties, including but not limited to its ability to manage expenses, access capital, and resolve internal control weaknesses. There is no guarantee the company will be able to continue as a going concern.

Summary for Investors

HCMC’s 2025 Annual Report reveals a company undergoing significant financial restructuring while facing persistent losses and material weaknesses in internal controls. The settlement of large debts and issuance of significant new shares (with dilution risk) are critical factors for investors. The available credit line provides some liquidity relief, but execution risks remain high. Investors should closely monitor management’s progress in cost reduction, capital raising, internal control remediation, and commercialization of its intellectual property and product lines. These developments have the potential to impact the company’s share price, especially if dilution or financing challenges arise.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. All forward-looking statements are subject to risks and uncertainties. Investors should consult the full SEC filings and seek professional advice before making investment decisions.

View Healthier Choices Management Corp. Historical chart here